A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

K L Lindsay; C Trepo; T Heintges; M L Shiffman; S C Gordon; J C Hoefs; E R Schiff; Z D Goodman; M Laughlin; R Yao

doi:10.1053/jhep.2001.26371

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

NobleID: NI2P45W20R03S61
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/2C43FFF7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2C43FFF7.svg?ark=w1%2F20260515%2F2C43FFF7&value=id)](https://nobleid.org/work/w1/20260515/2C43FFF7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C.

NobleID: NI2P45W20R03S61
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/2C43FFF7

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2C43FFF7.svg?ark=w1%2F20260515%2F2C43FFF7&value=id)](https://nobleid.org/work/w1/20260515/2C43FFF7)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work